A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease (FLOW)
Do you have Type 2 Diabetes? Have you ever experienced kidney problems?
Participating in a clinical study can improve future treatment options for you and other people with type two diabetes and chronic kidney disease.
In a study called FLOW, we will check to see if a therapy for lowering blood glucose in people with type 2 diabetes, can also slow down the progression and worsening of chronic kidney disease in these people.
You may qualify to participate in the FLOW study if:
- You have been diagnosed with kidney disease
- You are 18 years old or older
- You have been diagnosed with type 2 diabetes
- You are able to attend regular clinic visits and receive phone calls over a period of 3–5 years
What are the benefits of being involved in the FLOW study?
- Study-related care, including regular health check-ups
- General talks with a dedicated team of doctors and nurses
- Guidance on healthy lifestyle choices
For questions about this study, please reach out to Sofia Dayi:
- Phone: (352) 273-6662
- Email: firstname.lastname@example.org
Can be done from home
KeywordsKidney disease, Kidney disease - resources
Principal InvestigatorParta Hatamizadeh, MD, MPH
Begin a new search for other research studies
Studies listed on this site have been approved by a UF Institutional Review Board (IRB), which works to ensure the welfare and rights of research participants as required by federal regulations. Study listings are provided by the UF Clinical and Translational Science Institute in collaboration with UF research teams and the UF IRBs.